BINDING MEMBERS

EPCAM BINDING PROTEINS AND METHODS OF USE

COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS

Miniaturized antibody of anti-glucocorticoid-induced tumor necrosis factor receptor (GITR), and polymer and use thereof

ANTI-PD-1 ANTIBODY AND MEDICAL USE THEREOF

ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF

ANTI-CD47 ANTIBODIES

TRISPECIFIC ANTIBODY TARGETING BCMA, GPRC5D, AND CD3

METHODS AND COMPOSITIONS FOR INDUCING NOTCH SIGNALING IN TUMOR MICROENVIRONMENTS

ANTI-CD47/ANTI-LAG-3 BISPECIFIC ANTIBODY, PREPARATION METHOD THEREFOR AND USE THEREOF

Doppel-targeting antibodies

ANTI-MESOTHELIN ANTIBODIES

ANTIBODY AGAINST THE OPRF PROTEIN OF PSEUDOMONAS AERUGINOSA, USE THEREOF AS A MEDICAMENT AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

HIV BINDING AGENTS

Parvovirus Antibodies for Veterinary Use

Dual cytokine fusion proteins comprising IL-10

SIALIDASE-RESISTANT SACCHARIDE AND METHOD OF MAKING AND USING THE SAME

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY

BISPECIFIC BINDING CONSTRUCTS

BISPECIFIC ANTIBODY BINDING TO CD40 AND FAP

ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER

Methods and compositions relating to adenosine receptors

ANTIBODIES BINDING TO GPRC5D

BISPECIFIC ANTIBODIES SPECIFIC FOR PD1 AND TIM3

CD33 ANTIBODIES AND METHODS OF USING THE SAME TO TREAT CANCER

NKG2A ANTIBODY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

ANTI-IL-27 ANTIBODIES AND USES THEREOF

ActRIIa and ALK4 polypeptides for treating kidney fibrosis, inflammation and injury

COMPLEMENT C3 ANTIGEN BINDING PROTEINS

Binding moieties for biofilm remediation

NOVEL FUSION PROTEIN AND USE OF SAME

Anti-LAG3 antibodies and antigen-binding fragments

HYBRIDOMA, METHOD FOR MAKING THE SAME, MONOCLONAL ANTIBODY, AND METHOD FOR MAKING THE SAME

BINDING MOLECULES FOR BCMA AND CD3

Modified antigen binding polypeptide constructs and uses thereof

Antibodies for Botulinum Neurotoxins

Multi-specific binding proteins for cancer treatment

MONOCLONAL ANTIBODIES AND METHODS OF USE

IL-6Ralpha/IL-8R BISPECIFIC BINDING AGENTS FOR INHIBITING CANCER CELL MIGRATION

N-terminal scFv multispecific binding molecules

METHODS OF USE OF ANTI-SORTILIN ANTIBODIES FOR TREATING A DISEASE, DISORDER, OR INJURY

IMMUNOTHERAPY TARGETING CELL SURFACE MARKER CD72 FOR THE TREATMENT OF B-CELL MALIGNANCIES

Anti HLA-G specific antibodies

ANTI-NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 (NY-ESO-1) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

Anti-B7-H4 antibodies and immunoconjugates

A NOVEL ANTI-PD-L1 ANTIBODY AND USE THEREOF

CANINIZED ANTIBODIES TO HUMAN CTLA-4

Caninized Antibodies Against Canine CTLA-4

BISPECIFIC BINDING PROTEINS AND USES THEREOF

FUSIONS OF MUTANT INTERLEUKIN-2 POLYPEPTIDES WITH ANTIGEN BINDING MOLECULES FOR MODULATING IMMUNE CELL FUNCTION

CD137- and DLL3-targeting multispecific antigen-binding molecules

Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody

CD200R AGONIST ANTIBODIES AND USES THEREOF

ANTI-PD-1/LAG3/TIGIT TRISPECIFIC ANTIBODIES AND ANTI-PD-1/LAG3 BICPECIFIC ANTIBODIES

AGENTS THAT INTERFERE WITH THYMIC STROMAL LYMPHOPOIETIN (TSLP)-RECEPTOR SIGNALING

HUMAN ANTIBODIES TO BONE MORPHOGENETIC PROTEIN 6

Antibodies to amyloid beta

METHODS AND COMPOSITIONS RELATING TO ANTI-NUCLEOLIN RECOMBINANT IMMUNOAGENTS

FUSION PROTEIN COMPRISING ANTI-MESOTHELIN ANTIBODY, ANTI-CD3 ANTIBODY OR ANTI-EGFR ANTIBODY, BISPECIFIC OR TRISPECIFIC ANTIBODY COMPRISING SAME, AND USES THEREOF

Compositions and methods for treating and preventing infections

Anti-spike glycoprotein antibodies and the therapeutic use thereof

BI-SPECIFIC BINDING AGENTS TARGETING SYNDECAN-1 AND FIBROBLAST GROWTH FACTOR RECEPTOR

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES

ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF

ANTIBODIES AGAINST PD-1 AND METHODS OF USE THEREOF

Identification of immunologically protective neo-epitopes for the treatment of cancers

RECOMBINANT FAP BINDING PROTEINS AND THEIR USE

NOVEL IMMUNOCONJUGATES

ANTIBODY POLYPEPTIDES AND USES THEREOF

Anti-CEACAM5 monoclonal antibody and preparation method thereof and use thereof

4-1BB AND OX40 BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS, ANTIBODIES AGAINST 4-1BB, ANTIBODIES AGAINST OX40

Anti-4-1BB antibody and use thereof

BISPECIFIC NANOBODIES

Antigen Binding Proteins that Bind PD-1

CD3 antibody and pharmaceutical use thereof

ANTI-CD166 ANTIBODIES AND USES THEREOF

Anti-abeta antibodies

ANTIBODY DIRECTED AGAINST THE APOE AMINO-TERMINAL FRAGMENT OF 12KDA

Humanized anti-A β monoclonal antibody and application thereof

HUMANIZED ANTI-A[BETA] MONOCLONAL ANTIBODY AND APPLICATION THEREOF

Method for controlling affinity of antibody for antigen, antibody whose affinity for antigen has been altered, and its production method

Anti-IgE antibodies

HUMANIZED ANTIBODIES TO MUCIN-16 AND METHODS OF USE THEREOF

ANTI-NOTCH3 ANTIBODY

Antigen binding molecule formats

Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL)

SYNTHETIC ANTIBODIES AGAINST VEGF AND THEIR USES

ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF

Antibody cocktail against SARS-CoV-2 spike protein

NOVEL ANTI-HEPATITIS B VIRUS ANTIBODY AND USES THEREOF

Soluble Universal ADCC-Enhancing Synthetic Fusion Gene and Peptide Technology and Its Use Thereof

NOVEL INTERLEUKIN-2 VARIANTS FOR THE TREATMENT OF CANCER

ANTI-ADAM8 ANTIBODIES AND USES OF THE SAME

Anti-TEM1 antibodies and antigen-binding portions thereof

ANTI-PD-L1 ANTIBODY

ANTI-ROR1 / ANTI-CD3 BISPECIFIC BINDING MOLECULES

Anti-ILT3 antibodies and antibody drug conjugates

NOVEL MODULATORS

ANTI-ADRENOMEDULLIN (ADM) BINDER FOR USE IN THERAPY OR PREVENTION OF SYMPTOMS OF ILLNESS

Neutralizing antibodies to circumsporozoite protein and their use

APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF

BINDING MOLECULES

Multispecific Anti-HIV Antibodies

CORONAVIRUS-BINDING MOLECULES AND METHODS OF USE THEREOF

Engineered immunoglobulin heavy chain-light chain pairs and uses thereof

Bivalent, bispecific binding proteins for prevention or treatment of HIV infection

Anti-EGFR antibody-drug conjugates

Ciliary Neurotrophic Factor Receptor Ligands and Methods of Using the Same

T cell activating bispecific antigen binding molecules

Treatment of allergic diseases with chimeric protein

High-affinity anti-MERTK antibodies and uses thereof

Antibodies and antigen binding peptides for factor XIa inhibitors and uses thereof

AFFINITY MATURATED TAG72 SPECIFIC SINGLE CHAING ANTIBODIES

BINDING MOLECULES

ANTI-C-MET AGONIST ANTIBODY AND USE THEREOF

Anti-c-Met agonist antibody and use thereof

Anti-GPRC5D monoclonal antibodies and uses thereof

FULLY HUMAN ANTIBODY TARGETING CD19 AND APPLICATION THEREOF

ANTI-LAG-3 BINDING MOLECULES

Antibody specific for CD22 and methods of use thereof

ANTI-ALPHA-SYNUCLEIN ANTIBODIES

METHOD FOR IMPROVING AFFINITY OF ANTIBODY FOR ANTIGEN AND USE THEREOF

Separation moieties and methods of use thereof

COMBINATION THERAPY

Non-Human Animals Expressing pH-Sensitive Immunoglobulin Sequences

T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

T cell activating bispecific antigen binding molecules

Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and T cell receptor

Bispecific polypeptides against CD137

MÜLLERIAN INHIBITING SUBSTANCE TYPE 2 RECEPTOR (MISIIR)-SPECIFIC CAR T CELLS FOR THE TREATMENT OF OVARIAN CANCER AND OTHER GYNECOLOGIC MALIGNANCIES

ANTI-TIE2 ANTIBODY AND USE THEREOF

ANTI-GPIIB/IIIA ANTIBODIES OR USES THEREOF

ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS

BIFUNCTIONAL FUSION PROTEIN AGAINST PDL1 AND TGFß AND USE THEREOF

BISPECIFIC ANTIBODIES AGAINST CHI3L1 AND PD1 WITH ENHANCED T CELL-MEDIATED CYTOTOXIC EFFECTS ON TUMOR CELLS

Humanized anti-complement factor Bb antibodies and uses thereof

METHODS AND SYSTEMS FOR DETECTING CORONAVIRUS

Method for improving affinity of antibody for antigen and use thereof

Anti-complement C1s antibodies and uses thereof

Antibodies that recognize red blood cell antigens

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

ANTI-CD137 MOLECULES AND USE THEREOF

Anti-NPR1 antibodies and uses thereof

FC-MODIFIED BIOLOGICALS FOR LOCAL DELIVERY TO COMPARTMENTS, IN PARTICULAR TO THE CNS

Efflux Pump-Cancer Antigen Multi-Specific Antibodies and Compositions, Reagents, Kits and Methods Related Thereto

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

ANTIBODY BINDING TO PD-1

Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A)

Humanized anti-human CD19 antibodies and methods of use

Caninized antibodies

Anti-CD47 antibodies and uses thereof

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

PROTEIN BINDERS FOR IRHOM2

Antibody or chimeric antigen receptor which targets Claudin 18.2

NOVEL CTHRC1-SPECIFIC ANTIBODY AND USE THEREOF

Antibody molecules and uses thereof

Ha binding agents

VARIABLE LYMPHOCYTE RECEPTORS THAT TARGET THE BLOOD BRAIN BARRIER AND METHODS OF USE

System and Method for Improved Transient Protein Expression in CHO Cells

ANTIBODIES AND COMPOSITIONS FOR USE IN DETECTING OR CAPTURING A POLYPEPTIDE IN A SAMPLE, AND METHODS FOR DETECTING OR CAPTURING A POLYPEPTIDE IN A SAMPLE

Heavy chain antibodies binding to PSMA

Bispecific antibodies against CEACAM5 and CD47

ANTI-CD371 ANTIBODIES AND USES THEREOF

IMMUNOGLOBULIN PROTEINS THAT BIND TO NPR1 AGONISTS

Anti-CCR8 monoclonal antibodies and uses thereof

ANTI-INTEGRIN ANTIBODIES AND USES THEREOF

Fc-MODIFIED BIOLOGICALS FOR LOCAL DELIVERY TO COMPARTMENT, IN PARTICULAR TO THE CNS

ANTI-PD-1 ANTIBODIES AND USES THEREOF

Antibodies binding human and monkey CD3 and uses thereof

Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

NEUTRALIZING ANTIBODIES TO HUMAN ENDOTHELIN

Anti-interleukin-6 receptor antibodies

Antigen binding molecule formats

Anti-TGF-beta antibodies and their use

Monoclonal Antibodies to ELTD1 and Uses Thereof

ANTI-CSP ANTIBODY VARIANTS

Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof

ALBUMIN BINDING ANTIBODIES AND USE THEREOF

Neutralizing anti-SARS-CoV-2 antibodies

Compositions and methods for internalizing enzymes

Anti-complement C1s antibodies and uses thereof

Novel bispecific binding molecule and drug conjugate thereof

Antibodies that specifically bind to TL1A and methods of treating gastrointestinal disease

Bispecific antibodies binding ALK-1 and BMPR-2

HUMAN ANTIBODIES THAT BIND RET AND METHODS OF USE THEREOF

METHODS OF INCREASING PROGRANULIN LEVELS USING ANTI-SORTILIN ANTIBODIES

METHODS OF USE OF ANTI-SORTILIN ANTIBODIES FOR TREATING A DISEASE, DISORDER, OR INJURY

ANTI-AXL ANTIBODIES

METHODS OF REDUCING LARGE GRANULAR LYMPHOCYTE AND NATURAL KILLER CELL LEVELS

BINDING MOLECULES BINDING PD-L1 AND LAG-3

LAG-3 binding members

Anti-CD100 antibodies and methods for using the same

METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3

ANTI-CLAUDIN 18.2 ANTIBODY AND APPLICATION THEREOF

ANTI FGF23 ANTIBODY

NOVEL ANTI-TROPONINT ANTIBODIES

ENGINEERED ANTIBODY FOR INHIBITION OF FIBROSIS

Methods to identify immunogens by targeting improbable mutations

MICE THAT MAKE VL BINDING PROTEINS

Compositions and methods related to tumor activated antibodies targeting PSMA and effector cell antigens

Anti-CD98hc VNARs for crossing the blood brain barrier and type IV VNAR libraries

Nucleic acids encoding antagonistic CD40 monoclonal antibodies

Antibodies to canine and feline oncostatin M receptor beta and uses thereof

ANTI-AXL ANTIBODIES AND METHODS OF USE THEREOF

ANTI PD-L1 ANTIBODY AND USE THEREOF

CD8 BINDING AGENTS

CD22 ANTIBODIES AND METHODS OF USING THE SAME

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Method of preparing pH-dependent antibodies

COMBINATION THERAPIES USING ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES

Antibody molecules to dengue virus and uses thereof

Compositions for increasing half-life of a therapeutic agent in livestock animals and methods of use

CONDITIONING METHODS FOR GENE THERAPY

NON-HUMAN ANIMALS HAVING AN IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION THAT INCLUDES AN ENGINEERED DIVERSITY CLUSTER AND USES THEREOF

ANTI-HER2 BINDING MOLECULES

ANTIBODIES TO NEOANTIGENS AND USES THEREOF

Method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugate

Anti-Jagged1 antigen binding proteins

Methods of intravenouisly delivering anti-transferrin antibody/oligonucleotide complexes to subjects having muscular dystrophy

Antagonistic CD40 monoclonal antibodies and uses thereof

Methods of Engineering Surface Charge for Bispecific Antibody Production

Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)

BISPECIFIC ANTIBODIES AND USES THEREOF

Anti-lag-3 antibody polypeptide

IL-7 binding proteins and their use in medical therapy

Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

Afucosylated Anti-FGFR2IIIB Antibodies

Heterodimeric antibodies that bind CD3 and tumor antigens

Factor XI antibodies and methods of use

Anti-FXI/FXIa antibody and use thereof

ANTIBODY VARIANTS WITH PH-DEPENDENT ANTIGEN BINDING FOR SELECTIVE TARGETING OF SOLID TUMORS

COMPOSITION

ANTI-CD73 MONOCLONAL ANTIBODY AND APPLICATION THEREOF

ENGINEERING OF AN ANTIBODY FOR TUMOR-SELECTIVE BINDING OF CD47

ANTI BDCA-2 ANTIBODIES

Anti-B7-H4 antibodies and immunoconjugates

Anti-CD112R compositions and methods

Anti-CD48 antibodies, antibody drug conjugates, and uses thereof

Antibodies having specificity for BTN2 and uses thereof

ANTI-CD79B ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND PHARMACEUTICAL USE THEREOF

Methods of treating FGF21-associated disorders

EPITOPES IN THE RNA RECOGNITION MOTIF 1 (RRM1) OF TDP-43 AND MISFOLDING-SELECTIVE ANTIBODIES THERETO

MONOVALENT ANTI-PROPERDIN ANTIBODIES AND ANTIBODY FRAGMENTS

LILRB1-based chimeric antigen receptor

Antibodies specific to glycosylated PD-L1 and methods of use thereof

Method of Selecting for Antibodies

ANTIGEN-BINDING MOLECULE CONTAINING ANTIGEN-BINDING DOMAIN OF WHICH BINDING ACTIVITY TO ANTIGEN IS CHANGED DEPENDING ON MTA, AND LIBRARY FOR OBTAINING SAID ANTIGEN-BINDING DOMAIN

Antibody against factor XIa in activated form of coagulant factor XI, preparation method therefor and use thereof

Anti-Tissue Factor Antibodies, Antibody-Drug Conjugates, and Related Methods

MUC16 specific chimeric antigen receptors and uses thereof

MUC16 specific chimeric antigen receptors and uses thereof

Novel Fusion Proteins Specific for CD137 and GPC3

PRAME BINDING MOLECULES AND USES THEREOF

ANTI-TROPHOBLAST CELL SURFACE ANTIGEN 2 (TROP2) ANTIBODIES AND ANTIBODY DRUG CONJUGATES COMPRISING SAME

GLYCOPHORIN A ANTIGEN-BINDING PROTEINS

Antagonistic CD40 monoclonal antibodies and uses thereof

CD25 Antibodies

Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R)

Anti-MET antibodies and uses thereof

ANTI-HLA-DQ2.5 ANTIBODY

ANTI-ALPHABETATCR ANTIBODY

ANTI-ALPHA BETA TCR BINDING POLYPEPTIDES WITH REDUCED FRAGMENTATION

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3

Anti-MARCO antibodies and uses thereof

Anti-tumor necrosis factor (TNF) antibodies and compositions thereof

ANTIBODIES RECOGNIZING TAU

ANTIBODY MOLECULES AND USES THEREOF

COMPOUNDS SPECIFIC TO CORONAVIRUS S PROTEIN AND USES THEREOF

LILRB1-based chimeric antigen receptor

Compositions for making and using anti-Myostatin antibodies

Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)

COMPOUNDS AND METHODS TARGETING HUMAN TAU

Chemically-Locked Bispecific Antibodies

Antagonistic CD40 monoclonal antibodies and uses thereof

NOVEL ANTI-IFNAR1 ANTIBODIES

Anti-PD-L1 antibodies and variants

ANTI-VISTA ANTIBODIES AND FRAGMENTS

VISTA-BINDING ANTIBODIES AND USES THEREOF

Methods of treating systemic lupus erythematosus using a domain antibody directed against CD28

ANTI-CD47 ANTIBODIES AND USES THEREOF

TREATMENT OF CANCER METASTASIS BY TARGETING EXOSOME PROTEINS

PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODY AGAINST IL-5 AND USE THEREOF

Humanized anti-IL17A antibody and application thereof

Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumor necrosis factor (TNF) antibody

ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES AND METHOD OF USE THEREOF

Humanized anti-VEGF monoclonal antibody

Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived antibodies therefor

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

Muscle targeting complexes and uses thereof for treating dystrophinopathies

INTERNALIZING BINDING MOLECULES TARGETING RECEPTORS INVOLVED IN CELL PROLIFERATION OR IN CELL DIFFERENTIATION

Methods of blood screening

ANTI-MERTK ANTIBODIES AND THEIR METHODS OF USE

Bispecific HER2 Ligands for Cancer Therapy

CD38 antibody

Humanized anti-CCR7 receptor antibodies

METHODS AND COMPOSITIONS RELATING TO CHEMOKINE RECEPTOR VARIANTS

Anti-HLA-G antibodies, compositions comprising anti-HLA-G antibodies and methods of using anti-HLA-G antibodies